Home › Neoplasie del sangue › Distretto di Columbia › Washington
Studi clinici su Neoplasie del sangue a Washington, DC
19 studi su Neoplasie del sangue cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · a 7 mi di distanza
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi di distanza
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
In reclutamentoFase 1/2Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
In reclutamentoFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · a 7 mi di distanza
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
In reclutamentoFase 1/2Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Longitudinal Studies of Patient With FPDMM
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 1/2Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
In reclutamentoStudio osservazionale
- The Center for Cancer and Blood Disorders, Bethesda · a 7 mi di distanza
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
In reclutamentoFase 1
- Childrens National Medical Center, Washington D.C.
Mosaic Trial for Stem Cell Transplant Recipients
In reclutamento
- Georgetown University School of Medicine, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · a 7 mi di distanza
- Nih/Nhlbi, Bethesda · a 7 mi di distanza
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
In reclutamentoFase 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · a 7 mi di distanza
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
In reclutamentoFase 1/2Volontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
In reclutamentoStudio osservazionale
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · a 7 mi di distanza
Studi su Neoplasie del sangue in altre città
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Seattle, WA18 studi
- Baltimore, MD18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Edison, NJ13 studi
- Nashville, TN13 studi
- Columbus, OH13 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Cancro ovarico23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.